FDA Clarifies Approach To Pediatric Drug Development - Life

On May 17, the U.S. Food & Drug Administration ("FDA") issued two important draft guidance documents, which clarify the agency's approach to requirements and incentives in the realm of pediatric drug development...

Related Keywords

United States , , Pediatric Drug Development , Us Food Drug Administration Jan , Drug Administration , Research Equity , Food Drug Administration Feb , Why Does Pediatric Drug Development , Voucher Program , Incentivize Pediatric Drug Development , How Do Congress , Us Food Drug Administration , Pharmaceuticals For Children , Pediatric Research Equity , National Library Of Medicine , Considerations Guidance , Regulatory Considerations Guidance , Scientific Considerations , Why Does Pediatric Drug Development Need , Incentivize Pediatric Drug , Drug Modernization Act , Pediatric Research Equity Act , Best Pharmaceuticals , Children Act , Rare Pediatric Disease Priority , Review Voucher Program , Rare Pediatric Disease Priority Review Voucher , Pediatric Exclusivity Provision , Federal Food , Cosmetic Act , Biologics Price , Innovation Act , What Notable Changes Are Included , New Guidance , Exclusivity Will Be More Challenging , Scientific Considerations Guidance , Pediatric Study , Pediatric Study Plan , Regulatory Considerations , Complying With , Research Equity Act , Pediatric Exclusivity Under , Pediatric Drug Development Under , Unofficial Guidance , Unapproved Use , Napproved Drugs , Status Report , Pediatric Exclusivity , Exclusivity Provision , Rare Pediatric Priority Review , National Library , Mondaq , Fda , Pediatric Drug , Rescription And Otc Drugs , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , Iotechnology Amp Nanotechnology ,